Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension

Author(s):  McElhiney Linda F

Issue:  Jan/Feb 2021 - Volume 25, Number 1
View All Articles in Issue

Page(s):  24-28

Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 1
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 2
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 3
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 4
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension Page 5

Download in electronic PDF format for $65

Abstract:  Pediatric patients are sensitive to bitter-tasting substances and often resist taking them orally; however, they do like sweet substances from birth through mid-adolescence. To improve compliance, compounding pharmacists need to consider the palatability of compounded medications in addition to stability, safety, and effectiveness. Metronidazole compounded oral suspension is commonly prepared with the benzoate ester because it does not have a bitter taste; however, it has been on backorder and unavailable for months. A palatable metronidazole compounded oral suspension needs to be developed using the metronidazole base in order to meet the treatment needs of pediatric patients and improve compliance during this shortage.

Related Keywords: Linda F, McElhiney, PharmD, RPh, MSP, FACA, FASHP, FAPC, metronidazole benzoate, children, taste perception, formulations, patient compliance, bitterness, amebicide, antibiotic, antiprotozoal agent, oral suspension bases

Related Categories: HRT, LEGAL, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, PROFESSIONAL ISSUES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
Jan/Feb 2021
Pg. 24-28

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400

Metronidazole Benzoate 70 mg/mL in SyrSpend SF Oral Suspension
Allen Loyd V Jr
Jul/Aug 2018
Pg. 320

Metronidazole 50-mg/mL in Oral Mix and Oral Mix SF Suspension
Allen Loyd V Jr
Jan/Feb 2021
Pg. 47

Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease
McElhiney Linda F
Sep/Oct 2013
Pg. 380-383

Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
Jul/Aug 2020
Pg. 287-295

Stability of Metronidazole Benzoate in SyrSpend SF One-Step Suspension System
Vu Nicole T
, Aloumanis Vasileios, Ben Michel J, Kupiec Thomas C, Patterson Evelyn K, Radke Joshua, Erickson Martin A III, Schneider Gary
Nov/Dec 2008
Pg. 558-564

Benzoate or Not to Benzoate: Cats Are the Question, To
Davidson Gigi S
Mar/Apr 2001
Pg. 89-90

View Sample
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
Mar/Apr 2019
Pg. 106-111